Drug Approval | October 09, 2022
Dipharma receives regulatory authorization for the new line at Its cGMP pilot plant
The company increases its efficiency and is able to face the growing demand for its services.
The company increases its efficiency and is able to face the growing demand for its services.
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
To set up 50 lifestyle modification centres across the UAE in the next 24 months
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Lenalidomide is used to treat various types of cancers.
Subscribe To Our Newsletter & Stay Updated
